📰 Michael Strapazon News
Page 5 - Michael Strapazon News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Michael Strapazon. Real-time updates on events, politics, business and more.
January 20, 2022
/PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that LUMAKRAS® (sotorasib) has been approved in Japan for the treatment of KRAS G12C-mutated positive,...
January 20, 2022
Press release content from PR Newswire. The AP news staff was not involved in its creation.
January 20, 2022
THOUSAND OAKS, Calif., Jan. 20, 2022 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that LUMAKRAS® (sotorasib) has been approved in Japan fo...
January 16, 2022
/PRNewswire/ -- Amgen (NASDAQ:AMGN) and AstraZeneca today announced TEZSPIRE™ (tezepelumab-ekko) is now available for shipment to wholesalers in the U.S....
January 11, 2022
THOUSAND OAKS, Calif. and WALTHAM, Mass., Jan. 11, 2022 /PRNewswire/ -- Amgen and Arrakis Therapeutics today announced a research collaboration focused on the discovery and... | January 11, 2022
January 10, 2022
/PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that the European Commission (EC) has granted conditional marketing authorization for LUMYKRAS®...
January 10, 2022
/PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that the European Commission (EC) has granted conditional marketing authorization for LUMYKRAS®...
January 10, 2022
/PRNewswire/ -- Amgen (NASDAQ:AMGN) and BioLabs LA at the Lundquist Institute today announced that Karma Biotechnologies has been awarded the second Amgen...
January 6, 2022
/PRNewswire/ -- Amgen (NASDAQ:AMGN) will virtually present at the 40th Annual J.P. Morgan Healthcare Conference at 11:15 a.m. ET on Tuesday, Jan. 11, 2022....
January 6, 2022
/PRNewswire/ -- Amgen (NASDAQ:AMGN) will virtually present at the 40th Annual J.P. Morgan Healthcare Conference at 11:15 a.m. ET on Tuesday, Jan. 11, 2022....